NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Emerging Indications for Hyperbaric Oxygen Treatment

Not Yet RecruitingPhase 4

Sponsor: Jay C. Buckey Jr.

Conditions: Post-COVID-19 Condition, Ulcerative Colitis, Crohn Disease, Calciphylaxis, Frostbite

Interventions: Hyperbaric oxygen treatment (HBOT), 100% Oxygen

This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially benefit from HBOT) using the Multicenter Registry for Hyperbaric Oxygen Treatment. The study team aims to collect ongoing data on how well HBOT treats these emerging indications, and to add these data to the growing HBO Registry. The research team hypothesizes that HBOT will result in improvements of the condition of the various emerging indications.

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Patients referred for HBOT with an emerging indication

Exclusion Criteria:

* Contraindication to hyperbaric oxygen treatment (untreated seizures, pneumothorax, significant pulmonary airspace pathology that might lead to pulmonary barotrauma, unmanageable confinement anxiety, chronic obstructive pulmonary disease with CO2 retention)
* Pregnant persons